Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Analysis & Investment Frameworks
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock analysis on Invetso. Review Shuttle Pharmaceuticals Holdings, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Shuttle Pharmaceuticals Holdings, Inc. Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: US
Shuttle Pharmaceuticals Holdings, Inc. Key Financial Metrics
- Market Cap: $2.07M
- Revenue: $N/A
- ROE: -408.33%
- ROIC: -312.04%
- Dividend Yield: N/A
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Shuttle Pharmaceuticals Holdings, Inc. Investment Frameworks
Invetso analyzes Shuttle Pharmaceuticals Holdings, Inc. (SHPH) across the following frameworks:
- Shuttle Pharmaceuticals Holdings, Inc. 10Y Growth Potential
- Shuttle Pharmaceuticals Holdings, Inc. Scenario Analysis
- Shuttle Pharmaceuticals Holdings, Inc. Risks & Opportunities
- Shuttle Pharmaceuticals Holdings, Inc. Economic Moat
- Shuttle Pharmaceuticals Holdings, Inc. Business Model
- Shuttle Pharmaceuticals Holdings, Inc. Management
- Shuttle Pharmaceuticals Holdings, Inc. SWOT Analysis
- Shuttle Pharmaceuticals Holdings, Inc. Porter's 5 Forces
- Shuttle Pharmaceuticals Holdings, Inc. PESTLE Analysis
- Shuttle Pharmaceuticals Holdings, Inc. ESG Analysis
